by National Jewish Health Credit: Pixabay/CC0 Public Domain For the first time, researchers have shown that a class of anti-fibrotic drugs slows the progression of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Research conducted in part at National Jewish Health showed that pirfenidone was safe and effective in these patients. The study,...